Prevention of mother-to-child transmission of HIV in the HAART era: patterns in use of neonatal prophylaxis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-2652
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Prevention of mother-to-child transmission of HIV in the HAART era: patterns in use of neonatal prophylaxis ; volume:11 ; number:1 ; day:10 ; month:11 ; year:2008 ; pages:1 ; date:12.2008
Journal of the International AIDS Society / International AIDS Society ; 11, Heft 1 (10.11.2008), 1, 12.2008
- Urheber
-
England, K.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1758-2652-11-S1-P218
- URN
-
urn:nbn:de:1111-2016052056029
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- England, K.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women
Assessing the emergence of drug resistance in a cohort of HIV infected pregnant women under HAART for prophylaxis of mother-to-child transmission (MTCT) followed in a referral center in Rio de Janeiro, Brazil
Retraction Note: effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women
Early diagnosis of HIV-1 infection in newborns, in the context of prevention of mother-to-child transmission with HAART (Perinatal Cohort ANRS Co 01)
Control of viral replication after cessation of HAART
Oral lesions among HIV seropositive individuals in an era of generic HAART: markers of HAART efficacy?
Economic evaluation of tenofovir disoproxil fumarate prophylaxis to prevent mother-to-child transmission of Hepatitis B virus infection: evidence from a lower-middle income country
Neonatal prophylaxis with antibiotic containing ointments does not reduce incidence of chlamydial conjunctivitis in newborns
Repopulation of the Vg2Vd2 Repertoire After Prolonged HAART
Tolerability of antiretroviral therapy (HAART) in elderly age
Updates in the Pharmacologic Prophylaxis and Treatment of Invasive Candidiasis in the Pediatric and Neonatal Intensive Care Units : Updates in the Pharmacologic Prophylaxis
Cost-effectiveness analysis of the prevention of mother-to-child transmission of HIV
Effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women
Assessing the emergence of drug resistance in a cohort of HIV infected pregnant women under HAART for prophylaxis of mother-to-child transmission (MTCT) followed in a referral center in Rio de Janeiro, Brazil
Retraction Note: effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women
Early diagnosis of HIV-1 infection in newborns, in the context of prevention of mother-to-child transmission with HAART (Perinatal Cohort ANRS Co 01)
Control of viral replication after cessation of HAART
Oral lesions among HIV seropositive individuals in an era of generic HAART: markers of HAART efficacy?
Economic evaluation of tenofovir disoproxil fumarate prophylaxis to prevent mother-to-child transmission of Hepatitis B virus infection: evidence from a lower-middle income country
Neonatal prophylaxis with antibiotic containing ointments does not reduce incidence of chlamydial conjunctivitis in newborns
Repopulation of the Vg2Vd2 Repertoire After Prolonged HAART
Tolerability of antiretroviral therapy (HAART) in elderly age
Updates in the Pharmacologic Prophylaxis and Treatment of Invasive Candidiasis in the Pediatric and Neonatal Intensive Care Units : Updates in the Pharmacologic Prophylaxis
Cost-effectiveness analysis of the prevention of mother-to-child transmission of HIV
Effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women
Assessing the emergence of drug resistance in a cohort of HIV infected pregnant women under HAART for prophylaxis of mother-to-child transmission (MTCT) followed in a referral center in Rio de Janeiro, Brazil
Retraction Note: effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women
Early diagnosis of HIV-1 infection in newborns, in the context of prevention of mother-to-child transmission with HAART (Perinatal Cohort ANRS Co 01)
Control of viral replication after cessation of HAART
Oral lesions among HIV seropositive individuals in an era of generic HAART: markers of HAART efficacy?
Economic evaluation of tenofovir disoproxil fumarate prophylaxis to prevent mother-to-child transmission of Hepatitis B virus infection: evidence from a lower-middle income country
Neonatal prophylaxis with antibiotic containing ointments does not reduce incidence of chlamydial conjunctivitis in newborns
Repopulation of the Vg2Vd2 Repertoire After Prolonged HAART
Tolerability of antiretroviral therapy (HAART) in elderly age
Updates in the Pharmacologic Prophylaxis and Treatment of Invasive Candidiasis in the Pediatric and Neonatal Intensive Care Units : Updates in the Pharmacologic Prophylaxis